PMC:7187150 / 652-965 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T15","span":{"begin":154,"end":161},"obj":"Body_part"},{"id":"T16","span":{"begin":193,"end":198},"obj":"Body_part"},{"id":"T17","span":{"begin":213,"end":218},"obj":"Body_part"}],"attributes":[{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A16","pred":"fma_id","subj":"T16","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A17","pred":"fma_id","subj":"T17","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ls — can inhibit the interaction between SARS-CoV-2 and ACE2, Josef Penninger, Ali Mirazimi, Nuria Montserrat and colleagues administered the recombinant protein to SARS-CoV-2-infected Vero E6 cells. Treatment of cells with hrsACE2 inhibited SARS-CoV-2 infection in a dose-dependent manner and attenuated propagat"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":41,"end":49},"obj":"Disease"},{"id":"T10","span":{"begin":165,"end":173},"obj":"Disease"},{"id":"T11","span":{"begin":242,"end":250},"obj":"Disease"},{"id":"T12","span":{"begin":253,"end":262},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"ls — can inhibit the interaction between SARS-CoV-2 and ACE2, Josef Penninger, Ali Mirazimi, Nuria Montserrat and colleagues administered the recombinant protein to SARS-CoV-2-infected Vero E6 cells. Treatment of cells with hrsACE2 inhibited SARS-CoV-2 infection in a dose-dependent manner and attenuated propagat"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T28","span":{"begin":185,"end":198},"obj":"http://purl.obolibrary.org/obo/CLO_0051719"},{"id":"T29","span":{"begin":213,"end":218},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T30","span":{"begin":266,"end":267},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"ls — can inhibit the interaction between SARS-CoV-2 and ACE2, Josef Penninger, Ali Mirazimi, Nuria Montserrat and colleagues administered the recombinant protein to SARS-CoV-2-infected Vero E6 cells. Treatment of cells with hrsACE2 inhibited SARS-CoV-2 infection in a dose-dependent manner and attenuated propagat"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":154,"end":161},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"ls — can inhibit the interaction between SARS-CoV-2 and ACE2, Josef Penninger, Ali Mirazimi, Nuria Montserrat and colleagues administered the recombinant protein to SARS-CoV-2-infected Vero E6 cells. Treatment of cells with hrsACE2 inhibited SARS-CoV-2 infection in a dose-dependent manner and attenuated propagat"}

{"project":"LitCovid-PubTator","denotations":[{"id":"27","span":{"begin":56,"end":60},"obj":"Gene"},{"id":"28","span":{"begin":41,"end":51},"obj":"Species"},{"id":"29","span":{"begin":170,"end":184},"obj":"Disease"},{"id":"30","span":{"begin":242,"end":262},"obj":"Disease"},{"id":"31","span":{"begin":190,"end":192},"obj":"CellLine"}],"attributes":[{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"Gene:59272"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"Tax:2697049"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"MESH:C000657245"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"MESH:C000657245"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"CVCL:4582"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ls — can inhibit the interaction between SARS-CoV-2 and ACE2, Josef Penninger, Ali Mirazimi, Nuria Montserrat and colleagues administered the recombinant protein to SARS-CoV-2-infected Vero E6 cells. Treatment of cells with hrsACE2 inhibited SARS-CoV-2 infection in a dose-dependent manner and attenuated propagat"}